With all complex clinical trials, MHRA’s top priority is the safety and wellbeing of the trial participants
MHRA statement on the PATHWAYS puberty blocker trial
February 20, 2026

With all complex clinical trials, MHRA’s top priority is the safety and wellbeing of the trial participants
Get In Touch With ADK Accountancy Today.